Get the Stockscreener App
7.04
18.12%
1.08
After Hours:
7.00
-0.04
-0.57%
Eyepoint Pharmaceuticals Inc Stock (EYPT) Forecast
The Eyepoint Pharmaceuticals Inc (EYPT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $47.40, representing a +573.32% increase from the current price of $7.04. The highest analyst price target is $48.23, and the lowest is $46.57.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EYPT Price Target
Average 66.00
(+837.55% Upside)
Is Eyepoint Pharmaceuticals Inc (EYPT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.45 | Neutral |
| STOCH(9,6) | 60.65 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0179 | Buy |
| ADX(14) | 16.78 | Neutral |
| William %R | -18.69 | Sell |
| CCI(14) | 126.25 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.9795
Buy
|
6.1174
Buy
|
| MA20 |
6.1957
Buy
|
6.0923
Buy
|
| MA50 |
5.9207
Buy
|
6.1677
Buy
|
| MA100 |
6.5532
Buy
|
6.7021
Buy
|
| MA200 |
7.7795
Sell
|
8.7295
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, EYPT could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 4 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on EYPT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.45 indicates that EYPT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 60.65 indicates that EYPT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that EYPT is oversold. This suggests that EYPT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.78 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 126.25 indicates that EYPT is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term EYPT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eyepoint Pharmaceuticals Inc financial reports and earnings history, Eyepoint Pharmaceuticals Inc (EYPT) stock could reach $39.59 by 2030, $423.21 by 2040 and $530.83 by 2050. See the projected annual prices until 2050 of the Eyepoint Pharmaceuticals Inc stock below:
- Eyepoint Pharmaceuticals Inc (EYPT) is expected to reach an average price of $317.99 in 2035, with a high prediction of $319.07 and a low estimate of $313.32. This indicates an $4,417% rise from the last recorded price of $7.04.
- Eyepoint Pharmaceuticals Inc (EYPT) stock is projected to chart a bullish course in 2040, with an average price target of $420.52, representing an $5,873% surge from its current level. The forecast ranges from a conservative $412.39 to a sky-high $423.21.
- Our analysts predict Eyepoint Pharmaceuticals Inc (EYPT) to jump 6,849% by 2045, soaring from $484.24 to an average price of $489.20, potentially reaching $491.09. While $484.24 is the low estimate, the potential upside is significant.
- Eyepoint Pharmaceuticals Inc (EYPT) stock is expected to climb by 2050, reaching an average of $529.98, a $7,428% jump from its current level. However, a wide range of estimates exists, with high and low targets of $530.83 and $518.52, respectively, highlighting the market's uncertainty.
Eyepoint Pharmaceuticals Inc Stock (EYPT) Year by Year Forecast
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2025
Eyepoint Pharmaceuticals Inc Stock (EYPT) is expected to reach an average price of $48.77 in 2025, with a high prediction of $61.91 and a low estimate of $35.63. This indicates an +592.78% rise from the last recorded price of $7.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $48.08 | $46.57 | $48.23 | +582.97% |
| July, 2025 | $50.79 | $48.58 | $51.06 | +621.39% |
| August, 2025 | $52.76 | $51.14 | $52.77 | +649.36% |
| September, 2025 | $54.80 | $53.22 | $54.85 | +678.41% |
| October, 2025 | $57.22 | $55.21 | $57.28 | +712.77% |
| November, 2025 | $59.35 | $57.72 | $59.38 | +742.99% |
| December, 2025 | $61.83 | $59.85 | $61.91 | +778.22% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2026
The predicted value for Eyepoint Pharmaceuticals Inc (EYPT) in 2026 is set at an average of $81.55. Estimates vary from a peak of $100.75 to a trough of $62.34, indicating an +1,058% surge from the present price of $7.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $64.09 | $62.34 | $64.11 | +810.39% |
| February, 2026 | $70.33 | $64.58 | $70.55 | +899.02% |
| March, 2026 | $78.67 | $70.60 | $80.75 | +1,017% |
| April, 2026 | $83.64 | $77.34 | $85.43 | +1,088% |
| May, 2026 | $83.02 | $80.20 | $84.59 | +1,079% |
| June, 2026 | $84.58 | $82.50 | $85.83 | +1,101% |
| July, 2026 | $86.07 | $83.88 | $87.88 | +1,123% |
| August, 2026 | $88.80 | $86.10 | $89.18 | +1,161% |
| September, 2026 | $89.97 | $89.06 | $90.95 | +1,178% |
| October, 2026 | $93.21 | $89.75 | $93.26 | +1,224% |
| November, 2026 | $97.06 | $93.52 | $97.39 | +1,279% |
| December, 2026 | $99.14 | $97.26 | $100.75 | +1,308% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eyepoint Pharmaceuticals Inc (EYPT) is $113.43, with a high forecast of $127.48 and a low forecast of $99.38. This indicates an +1,511% increase from the last price of $7.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $102.89 | $99.38 | $103.32 | +1,362% |
| February, 2027 | $110.18 | $102.54 | $114.44 | +1,465% |
| March, 2027 | $109.23 | $108.48 | $111.91 | +1,452% |
| April, 2027 | $107.60 | $107.17 | $111.64 | +1,428% |
| May, 2027 | $109.11 | $106.91 | $109.85 | +1,450% |
| June, 2027 | $113.83 | $109.30 | $114.21 | +1,517% |
| July, 2027 | $116.64 | $114.17 | $117.54 | +1,557% |
| August, 2027 | $119.10 | $117.02 | $119.37 | +1,592% |
| September, 2027 | $118.90 | $116.83 | $119.96 | +1,589% |
| October, 2027 | $119.21 | $118.31 | $120.11 | +1,593% |
| November, 2027 | $121.66 | $118.91 | $121.74 | +1,628% |
| December, 2027 | $127.15 | $121.13 | $127.48 | +1,706% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2028
In 2028, Eyepoint Pharmaceuticals Inc (EYPT) is projected to reach an average price of $139.48, with a high projection of $152.36 and a low estimate of $126.60. This indicates an +1,881% rise from the last price of $7.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $127.40 | $126.63 | $128.24 | +1,710% |
| February, 2028 | $128.15 | $126.65 | $128.56 | +1,720% |
| March, 2028 | $128.26 | $126.60 | $128.81 | +1,722% |
| April, 2028 | $128.28 | $128.01 | $129.36 | +1,722% |
| May, 2028 | $130.47 | $128.45 | $130.56 | +1,753% |
| June, 2028 | $133.89 | $130.98 | $134.96 | +1,802% |
| July, 2028 | $135.84 | $134.28 | $136.73 | +1,830% |
| August, 2028 | $136.83 | $135.74 | $137.79 | +1,844% |
| September, 2028 | $139.77 | $137.18 | $139.89 | +1,885% |
| October, 2028 | $145.15 | $140.25 | $147.97 | +1,962% |
| November, 2028 | $147.21 | $144.94 | $147.48 | +1,991% |
| December, 2028 | $152.03 | $147.52 | $152.36 | +2,060% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2029
The 2029 price forecast for Eyepoint Pharmaceuticals Inc Stock (EYPT) is $114.11 on average, with a high prediction of $194.05 and a low estimate of $34.16. This represents an +1,521% increase from the previous price of $7.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $158.45 | $151.60 | $158.61 | +2,151% |
| February, 2029 | $159.36 | $158.01 | $163.68 | +2,164% |
| March, 2029 | $160.63 | $158.40 | $162.40 | +2,182% |
| April, 2029 | $160.35 | $158.56 | $161.36 | +2,178% |
| May, 2029 | $161.28 | $159.05 | $162.87 | +2,191% |
| June, 2029 | $163.59 | $161.50 | $163.65 | +2,224% |
| July, 2029 | $182.19 | $174.81 | $183.70 | +2,488% |
| August, 2029 | $188.63 | $178.72 | $189.66 | +2,579% |
| September, 2029 | $190.34 | $188.88 | $194.05 | +2,604% |
| October, 2029 | $188.68 | $187.05 | $193.64 | +2,580% |
| November, 2029 | $186.17 | $185.23 | $191.64 | +2,544% |
| December, 2029 | $34.35 | $34.16 | $188.91 | +388.00% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2030
Eyepoint Pharmaceuticals Inc Stock (EYPT) is expected to reach an average price of $61.78 in 2030, with a high forecast of $88.23 and a low forecast of $35.32. This signifies an +777.52% surge from the last price of $7.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $39.41 | $35.32 | $39.59 | +459.78% |
| February, 2030 | $43.60 | $40.45 | $43.74 | +519.28% |
| March, 2030 | $47.58 | $44.55 | $47.68 | +575.80% |
| April, 2030 | $51.97 | $48.52 | $52.04 | +638.21% |
| May, 2030 | $57.52 | $52.95 | $57.52 | +717.10% |
| June, 2030 | $62.13 | $58.37 | $62.61 | +782.52% |
| July, 2030 | $66.59 | $63.09 | $66.72 | +845.82% |
| August, 2030 | $70.83 | $67.60 | $70.89 | +906.10% |
| September, 2030 | $75.11 | $71.86 | $75.16 | +966.88% |
| October, 2030 | $80.60 | $76.12 | $80.79 | +1,045% |
| November, 2030 | $84.04 | $81.26 | $84.22 | +1,094% |
| December, 2030 | $87.98 | $84.89 | $88.23 | +1,150% |
8.70%
1.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):